JAZZ
Jazz Pharmaceuticals PLC
Price:  
109.01 
USD
Volume:  
385,859.00
Ireland | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

JAZZ EV/EBITDA

15.9%
Upside

As of 2024-07-22, the EV/EBITDA ratio of Jazz Pharmaceuticals PLC (JAZZ) is 6.14. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. JAZZ's latest enterprise value is 11,141.27 mil USD. JAZZ's TTM EBITDA according to its financial statements is 1,813.80 mil USD. Dividing these 2 quantities gives us the above JAZZ EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 6.8x - 8.7x 7.4x
Forward P/E multiples 11.6x - 13.3x 12.7x
Fair Price 91.31 - 182.00 126.35
Upside -16.2% - 67.0% 15.9%
109.01 USD
Stock Price
126.35 USD
Fair Price

JAZZ EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-07-19 6.14
2024-07-18 6.14
2024-07-17 6.11
2024-07-16 6.04
2024-07-15 5.95
2024-07-12 6.02
2024-07-11 6.04
2024-07-10 5.91
2024-07-09 5.85
2024-07-08 5.85
2024-07-05 5.87
2024-07-03 5.95
2024-07-02 6.01
2024-07-01 6.05
2024-06-28 6.06
2024-06-27 6.08
2024-06-26 6.08
2024-06-25 6.11
2024-06-24 6.17
2024-06-21 6.11
2024-06-20 6.09
2024-06-18 6.27
2024-06-17 6.33
2024-06-14 6.28
2024-06-13 6.27
2024-06-12 6.21
2024-06-11 6.19
2024-06-10 6.14
2024-06-07 6.25
2024-06-06 6.05
2024-06-05 6.06
2024-06-04 5.99
2024-06-03 6.03
2024-05-31 6.01
2024-05-30 6.02
2024-05-29 5.98
2024-05-28 6.01
2024-05-24 6.04
2024-05-23 5.97
2024-05-22 6.02
2024-05-21 6.07
2024-05-20 6.13
2024-05-17 6.14
2024-05-16 6.19
2024-05-15 6.17
2024-05-14 6.25
2024-05-13 6.29
2024-05-10 6.16
2024-05-09 6.29
2024-05-08 6.20